X-gen Pharma emphasizes its commitment to providing affordable generic pharmaceuticals across various therapeutic categories, leveraging over 50 years of industry experience. The company focuses on innovation and quality, as evidenced by its recent product additions, including Desmopressin Acetate Injection and Cyclophosphamide for Injection. X-gen Pharma is dedicated to enhancing patient care through its extensive product catalog and adherence to compliance standards, such as the NABP Accreditation obtained in May 2022, which underscores its commitment to quality and regulatory compliance.

In addition to its product offerings, X-gen Pharma prioritizes customer engagement and support through various channels, including adverse event reporting and product quality complaint management. The company employs serialization and EDI capabilities to ensure efficient processing and tracking of its products, further enhancing its operational effectiveness. By fostering collaboration and maintaining strong industry relationships, X-gen Pharma aims to create opportunities for its customers and stakeholders while upholding its core values of authenticity and courage in addressing challenges.

United States

With over 50 years of experience in generic pharmaceuticals, we provide superior customer care and stay true to our core values, creating opportunities for our customers, our markets, our products and our people.

We provide affordable, necessary generic pharmaceuticals to enhance the lives of patients among many therapeutic categories.

X-gen Pharma

Company Details